Weekly Taxol Plus Xeloda Versus Taxotere Every Three Weeks Plus Xeloda in the Treatment of Metastatic Breast Cancer A Phase II/III Study.
Phase of Trial: Phase II/III
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Capecitabine (Primary) ; Docetaxel (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Oct 2005 New trial record.